Highly active antiretroviral therapy: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
mNo edit summary |
||
| Line 4: | Line 4: | ||
HAART does ''not'' include drugs that treat complications of [[AIDS]]. For example, while it is quite common to prescribe prophylactic antimicrobial agents to an immunosuppressed patient, these are adjuncts to HAART. Treatment of clinical manifestations such as [[HIV wasting syndrome]], are also complementary to HAART but not part of it. | HAART does ''not'' include drugs that treat complications of [[AIDS]]. For example, while it is quite common to prescribe prophylactic antimicrobial agents to an immunosuppressed patient, these are adjuncts to HAART. Treatment of clinical manifestations such as [[HIV wasting syndrome]], are also complementary to HAART but not part of it. | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 16:01, 27 August 2024
Highly active antiretroviral therapy (HAART) is a collection of "drug regimens, for patients with HIV infections, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a HIV protease inhibitor[1]
HAART does not include drugs that treat complications of AIDS. For example, while it is quite common to prescribe prophylactic antimicrobial agents to an immunosuppressed patient, these are adjuncts to HAART. Treatment of clinical manifestations such as HIV wasting syndrome, are also complementary to HAART but not part of it.
References
- ↑ Anonymous (2024), Highly active antiretroviral therapy (English). Medical Subject Headings. U.S. National Library of Medicine.